Skip to main content
. 2015 Nov 2;7(1):1055–1065. doi: 10.18632/oncotarget.6274

Table 4. strata analysis results : independents factors associated with Time to diagnosis, identified by multivariate analyses, for each tumor site.

Breast cancer Prostate cancer Sarcoma Lung cancer Colorectal cancer
univariate multivariate univariate multivariate univariate multivariate univariate multivariate univariate multivariate
HR [95%CI] p (LR) HR [95%CI] p (LR) HR [95%CI] p (LR) HR [95%CI] p (LR) HR[CI] p (LR) AHR [CI] p (LR) HR [95%CI] p (LR) AHR [95%CI] p (LR) HR [95%CI] p (LR) AHR [95%CI] p (LR)
AGE 0.68 [0.28-1.62] 0.71 [0.27-1.9] 1 (reference) 0.845 1 (reference) 0.726 1 (reference) 0.879
[19-55] 1 (reference) 0.419 1 (reference) 0.04 1 (reference) 0.034 0.66 [0.23-1.9] 0.86 [0.52-1.43] 0.98 [0.54-1.77]
[56-65] 1.17 [0.94-1.47] 0.54 [0.36-0.81] 0.52 [0.33-0.8] 1.11 [0.35-3.57] 1.05 [0.64-1.72] 1.17 [0.65-2.12]
[66-74] 1.19 [50.92-1.53] 0.67 [0.43-1.04] 0.55 [0.34-0.9] 0.84 [0.37-1.89] 1.1 [0.62-1.94] 1.12 [0.62-2]
[75-92] 1.12 [0.87-1.44]
GENDER
Female 1 (reference) 0.649 NA NA 1 (reference) 0.172 1 (reference) 0.623 1 (reference) 0.848 1 (reference) 0.89
Male 1.32 [0.42-4.11] 0.6 [0.29-1.23] 0.78 [0.29-2.08] 1.04 [0.73-1.47] 0.97 [0.67-1.42]
ECOG PS
0 1 (reference) 0.287 1 (reference) 0.005 1 (reference) 0.09 1 (reference) 0.009 1 (reference) 0.102 1 (reference) 0.359 1 (reference) 0.433
1 0.81 [0.64-1.02] 0.84 [0.59-1.2] 0.41 [0.18-0.92] 0.23 [0.09-0.61] 1.26 [0.79-2.01] 1.47 [0.8-3.38] 1.4 [0.92-2.14]
2 1.14 [0.64-2.03] 2.59 [1.38-4.87] 1.29 [0.34-4.89] 1.01 [0.2-5.2] 1.76 [1.02-3.03] 1.75 [0.82-3.75] 1.32 [0.76-2.31]
>2 0.79 0.33-1.92] 4.54 [1.41-14.66] 0.25 [0.03-1.99] 0.1 [0.01-1.71] 2.27 [1.01-5.1] 2.76 [0.71-10.66] 1.17 [0.42-3.24]
QUINTILE EDI
1 1 (reference) 0.628 1 (reference) 0.611 1 (reference) 0.103 1 (reference) 0.081 1 (reference) 0.68 1 (reference) 0.314 1 (reference) 0.994 1 (reference) 0.982 1 (reference) 0.755 1 (reference) 0.886
2 0.83 [0.61-1.14] 0.85 [0.62-1.16] 1.13 [0.67-1.92] 1.42 [0.8-2.51] 1.04 [0.26-4.24] 0.92 [0.12-7.28] 1.06 [0.59-1.89] 1.03 [0.46-2.32] 0.91 [0.47-1.77] 0.87 [0.42-1.78]
3 0.9 [0.66-1.23] 0.97 [0.71-1.32] 0.85 [0.47-1.54] 1.03 [0.54-1.97] 0.74 [0.2-2.8] 0.85 [0.12-6.12] 0.95 [0.52-1.75] 0.97 [0.44-2.13] 0.88 [0.44-1.75] 0.9 [0.43-1.9]
4 0.97 [0.72-1.31] 1.01 [0.75-1.37] 1.72 [0.96-3.06] 1.91 [1.02-3.58] 1.8 [0.41-7.78] 3.56 [0.49-25.9] 1.0 [0.56-1.81] 1.2 [0.54-2.67] 0.69 [0.34-1.38] 0.73 [0.34-1.53]
5 1.01 [0.77-1.34] 1.05 [0.79-1.4] 1.29 [0.74-2.25] 1.79 [0.93-3.43] 0.85 [0.23-3.11] 1.11 [0.14-8.8] 0.95 [0.55-1.65] 1.13 [0.53-2.38] 0.98 [0.53-1.81] 0.97 [0.5-1.9]
T staging
1 1 (reference) <0.001 1 (reference) <0.001 1 (reference) 0.153 1 (reference) 0.034 1 (reference) 0.174 1 (reference) 0.171 1 (reference) 0.145 1 (reference) 0.222
2 0.8 [0.66-0.98] 0.79 [0.64-0.97] 1.51 [1.05-2.17] 1.61 [1.07-2.45] NA 1.7 [0.92-3.14] 1.7 [0.86-3.38] 0.38 [0.09-1.54]
3 0.53 [0.33-0.83] 0.52 [0.33-0.81] 1.29 [0.83-2.01] 1.42 [0.86-2.34] NA 1.26 [0.67-2.4] 1.24 [0.61-2.53] 0.32 [0.1-1.05]
4 0.39 [0.23-0.64] 0.36 [0.21-0.61] 2.37 [0.32-17.37] 2.2 [0.3-16.69] NA 0.96 [0.49-1.91] 0.83 [0.39-1.76] 0.25 [0.08-0.85]
N staging 0.021
0 1 (reference) 1 (reference) 0.038 1 (reference) 0.414 1 (reference) 0.707 1 (reference) 0.141 1 (reference) 0.189
1 0.87 [0.71-1.06] 2.54 [1.16-5.55] 0.91 [0.16-5.1] 1.16 [0.57-2.35] 0.66 [0.42-1.06] 0.67 [0.42-1.09]
2 0.8 [0.56-1.16] NA 7.31 [0.44-121] 1.37 [0.78-2.41] 0.97 [0.55-1.73] 0.95 [0.52-1.76]
3 0.43 [0.22-0.84] NA NA 1.31 [0.67-2.57] NA NA
M status 0.031 <0.001
0 1 (reference) 1 (reference) 1 (reference) 0.125 1 (reference) 0.002 1 (reference) 0.62 1 (reference) 0.828
1 0.62 [0.39-0.99] 3.29 [1.89-5.72] 0.6 [0.29-1.23] 0.21 [0.07-0.62] 0.92 [0.65-1.29] 1.04 [0.71-1.52]